Global Infusion Pumps Market - 2025-2033

The global infusion pumps market reached US$ 16.4 billion in 2024 and is expected to reach US$ 26.5 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025-2033.

Infusion pumps are the medical devices that's delivers a patient to flow fluids externally and in a controlled format. There are basically many different types of infusion pumps which serve several different purposes and environments. An infusion pump can have a very wide range of delivery settings from large volume down to as low as micro delivery, and often are used in both TPN applications and various types of I.V. medications - insulin and hormones, chemotherapeutic agents, antibiotics, analgesics, etc. Some infusion pumps present themselves for use at the bedside; others are designed as ambulatory infusion pumps for portability or wearability.

Market Dynamics: Drivers & Restraints

Rapid Increase of Technological Advancements

At present, fast-growing technological advancement is taking an essential part in transforming the infusion pumps market worldwide. The advancements and innovations such as smart infusion pumps with wireless connections and drug libraries have contributed a lot toward drug delivery in terms of reliability and safety. Also integrated with high-tech features such as real-time monitoring, error reduction systems, and remote programming, these solutions are addressing critical issues about patient care in high-risk settings such as intensive care units.

For instance, in January 2024, a drug infusion pump with a technology for safely detecting medication administration has been developed for the first time globally. The Korea Institute of Machinery and Materials, led by Senior Researcher Dong-kyu Lee, developed customized sensor modules to measure the low flow rate of analgesic drug infusion pumps and the presence of bubbles. The safe pump system is being developed for mass production by Unimedics, a renowned manufacturer of medication injectors in Korea. This technology aims to prevent medical accidents caused by excessive analgesic drug administration.

Product Recalls

The market growth of global infusion pumps are hindered by product recalls. In fact, most recalls are triggered by manufacturing faults, software malfunctioning, or safety issues that lead to adverse patient exposure. This results into tarnishing brand names and is capable of causing a very transient stall in market growth. Recalls provoke greater scrutiny from regulators and cost Billions of dollars to be re-engineered into compliant products which directly affect the profitability of manufacturers.

For instance, in October 2024, Zyno Medical is recalled select Z800 infusion pumps due to a defect in the air-in-line software algorithm, potentially allowing a 1 mL air bubble to pass to a patient. The product may cause serious adverse health consequences, including vascular air embolism, tachyarrhythmia, myocardial infarction, stroke, seizure, and death. There have been two reported injuries.

Similarly, in April 2024, InfuTronix, LLC is recalled Nimbus infusion pump systems due to potential failure modes such as battery failure, upstream blockage, system errors, drug product leakage, high or low flow rate, or damaged housing, effective June 20, 2024.

Segment Analysis

The global infusion pumps market is segmented based on product type, technology, application, end user and region.

Product Type:

Syringe infusion pumps segment is expected to dominate the Infusion Pumps market share

The syringe infusion pumps segment holds a major portion of the infusion pumps market share and is expected to continue to hold a significant portion of the infusion pumps market share during the forecast period.

Syringe infusion pumps are a vital component of the global infusion pumps market, providing precise and controlled delivery of small volumes of fluids and medications. They are particularly useful in critical care settings like neonatal and pediatric care, where accuracy is crucial due to patients' small size and sensitivity to dosage errors. They are also crucial for administering high-potency drugs like chemotherapy agents, anesthetics, and pain management medications. Their compact design and ability to deliver medications at low flow rates make them ideal for hospital and ambulatory care. Advancements in syringe pump technology, such as dose error reduction systems and wireless connectivity, have enhanced their efficiency and safety.

For instance, in April 2024, Baxter International has received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, allows clinicians to use a single, integrated system across various patient care settings. Baxter's commitment to innovation in infusion therapy is demonstrated by offering the Novum IQ LVP in the U.S.

End User:-

Hospitals segment is the fastest-growing segment in Infusion Pumps market share

The hospitals segment is the fastest-growing segment in the infusion pumps market share and is expected to hold the market share over the forecast period.

Hospitals are the largest end-users of infusion pumps globally, providing precise and controlled dosages of fluids, medications, and nutrients to patients across various departments. The increasing incidence of chronic diseases, surgical procedures, and critical care requirements has increased demand for infusion pumps.

For instance, in April 2024, Mackenzie Health has introduced BD Alaris EMR Interoperability, a two-way information flow technology that enables two-way communication between an IV medication pump and a patient's electronic medical record. This eliminates the need for healthcare professionals to manually program pumps and send infusion safety information back to Epic EMR, thereby reducing administration errors and providing accurate infusion records.

Moreover, in April 2023, Nathan Littauer Hospital & Nursing Home has opted for B Braun Medical Inc.'s Infusomat Space 2nd Generation Large Volume Pumps due to their efficiency and accuracy, ensuring safer patient care for the hospital's patients.

Geographical Analysis

North America is expected to hold a significant position in the Infusion Pumps market share

North America holds a substantial position in the infusion pumps market and is expected to hold most of the market share due to its advanced healthcare infrastructure, FDA approvals, high healthcare expenditure, and early adoption of innovative medical technologies. The region's high prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders drives demand for infusion pumps. Major market players like Medtronic, Baxter, and B. Braun ensure continuous innovation and availability of cutting-edge products. The strong regulatory framework and emphasis on patient safety drive the adoption of smart infusion pumps with integrated error-reduction systems.

For instance, in May 2024, Moog Inc has secured 510(k) clearance from the United States Food and Drug Administration (FDA) for the CURLIN 8000 Ambulatory Infusion System in the Industrial segment. This high-end infusion platform has been designed specifically for use in home infusion facilities.

Moreover, in July 2023, Becton, Dickinson and Company, or BD, is a global leader in medical technology that announced that the BD Alaris update, the latest version of the BD Alaris Infusion System, has been granted 510(k) clearance by the United States Food and Drug Administration (FDA) to remediate and then return to full commercial operations for the most comprehensive use-infusion system in the United States.

Europe is growing at the fastest pace in the Infusion Pumps market

Europe holds the fastest pace in the infusion pumps market and is expected to hold most of the market share due to aging population and chronic diseases. Countries like Germany, France, and the UK lead the market due to their advanced healthcare systems. The focus on personalized medicine and homecare has increased demand for portable infusion pumps. The European Union's focus on reducing hospital stays and promoting outpatient care has fueled the adoption of infusion technology in ambulatory settings. Government funding, collaborations, and competitive pricing from local and international manufacturers drive market growth.

For instance, in May 2023, Fresenius Kabi announced that it has joined Premier, Inc. in a Breakthrough Technology group purchasing agreement. Under the agreement, which comes into effect May 1, 2023, Premier members may opt to take advantage of special pricing and terms negotiated in advance by Premier for the Ivenix Infusion System from Fresenius Kabi.

Competitive Landscape

The major global players in the infusion pumps market include Medtronic plc, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical, Inc, Terumo Corporation, Micrel Medical Devices SA, Moog Inc, Mindray Medical International, Ltd, BD (Becton, Dickinson and Company) and among others.

Key Developments

• In June 2023, B. Braun Medical Inc. has launched DoseTrac Enterprise Infusion Management Software, a next-generation infusion management software. The software offers real-time views and retrospective reporting features to help organizations understand their infusion pump fleet and associated data. It can connect up to 40,000 pumps at an unlimited number of facilities with just one application.
• In February 2023, Mindray has introduced its BeneFusion i Series and u Series infusion systems, offering high precision, adaptive customization, and simplicity for medication safety in various clinical settings, available in select countries and regions.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global infusion pumps market report delivers a detailed analysis with 68+ key tables, more than 72 visually impactful figures, and 236 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.